Lexaria Appoints Michael Shankman as Chief Financial Officer
KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces the appointment of Michael Shankman, CPA, as Chief Financial Officer… Read More